Elucid’s Next-Generation Plaque Analysis and FFRCT Technology to be Featured on 2022 AHA Scientific Sessions Program
November 4th, 2022 | 🕒
iSpeech BOSTON--(BUSINESS WIRE)--Elucid, Inc., a medical technology company providing physicians AI-powered imaging analysis software to characterize cardiovascular disease, has announced
Gloss